← Back to Search

Corticosteroid

Corticosteroid alone (CS) Group for Trigger Finger

Phase 4
Waitlist Available
Led By Kenneth Taylor, MD
Research Sponsored by Kenneth Taylor, M.D.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up patients are assessed pre-injection (baseline), 1 minute post-injection, 10 minutes post-injection, at 6 weeks post-injection and also asked to recollect their pain at time of injection when seen at 6 weeks post-injection
Awards & highlights
All Individual Drugs Already Approved
Approved for 60 Other Conditions
Drug Has Already Been Approved
No Placebo-Only Group
Pivotal Trial

Summary

This research is being done to compare pain relief and efficacy of trigger finger injection using a combination of lidocaine/corticosteroid versus corticosteroid injection alone versus corticosteroid/saline combination.

Eligible Conditions
  • Trigger Finger

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~patients are assessed pre-injection objectively by investigator and at 6 weeks post-injection subjectively via patient survey
This trial's timeline: 3 weeks for screening, Varies for treatment, and patients are assessed pre-injection objectively by investigator and at 6 weeks post-injection subjectively via patient survey for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
VAS
Secondary study objectives
Degree of Triggering
Number of Participants With Adverse Effects
Presence of Triggering

Awards & Highlights

All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
Approved for 60 Other Conditions
This treatment demonstrated efficacy for 60 other conditions.
Drug Has Already Been Approved
The FDA has already approved this drug, and is just seeking more data.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.

Trial Design

3Treatment groups
Active Control
Group I: Corticosteroid alone (CS) GroupActive Control1 Intervention
1 cc dexamethasone sodium phosphate (4mg/ml) injectable
Group II: Corticosteroid/Lidocaine (CSL) GroupActive Control2 Interventions
1 cc dexamethasone sodium phosphate (4 mg/ml) injectable and 1 cc 1% Xylocaine (lidocaine) injectable
Group III: Corticosteroid/Saline (CSS) GroupActive Control2 Interventions
1 cc dexamethasone sodium phosphate (4mg/ml) injectable and 1 cc 0.9% injectable Sodium Chloride (saline)

Find a Location

Who is running the clinical trial?

Kenneth Taylor, M.D.Lead Sponsor
2 Previous Clinical Trials
64 Total Patients Enrolled
Kenneth Taylor, MDPrincipal InvestigatorMilton S. Hershey Medical Center
2 Previous Clinical Trials
64 Total Patients Enrolled
~2 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top